On the way to colleges: 40,000 doses of opioid-blocker naloxone, the ‘Lazarus drug’
Injectable and nasal spray formulations of naloxone, which can be used to block the potentially fatal effects of opioid overdoses, are shown at an outpatient pharmacy at the University of Washington. (Photo: Ted S. Warren/AP)/ As the U.S. government and health care providers grapple with the exploding rates of opioid abuse across the country, the Clinton Foundation has expanded its partnership with Adapt Pharma, maker of Narcan nasal spray, by donating 40,000 doses of the opioid overdose reversal drug to colleges and universities throughout ...
Click
To Read Full Article